March 27 (Yesterday) Quick Overview of the Profit Effect of Continuous Limit-up Stocks

StrawberryIce · 2026-03-27T22:06:02+00:00

Yesterday, the market sentiment for consecutive limit-up stocks improved, with 11 stocks hitting the limit-up, including 3 that achieved four consecutive limit-ups. High-priced stocks performed strongly, with a 0% upgrade rate for mid-cap stocks and poor performance. Low-priced stocks showed significant differentiation, with sectors like pharmaceuticals and electricity performing relatively well, while non-mainline stocks experienced notable losses. It is advisable to invest in high-priced leading stocks and low-priced stocks within the mainline sectors, and to avoid mid-cap stocks and non-mainline stocks.

StrawberryIce

2026-03-27 22:06:02

Abstract generation in progress

(Yesterday) Quick Overview of Continuous Board Stocks Profitability
Overall Conclusion: Sentiment warming, high positions strong, mid positions weak, profitability differentiation

Core Data

Total number of continuous boards: 11 (including ST)
Highest continuous board: 4 consecutive boards (3 stocks): Meinuohua, Xinneng Taishan, Rongjie Co., Ltd.
Advancement rate:
3 to 4: 100% (3 stocks fully advanced)
2 to 3: 0% (mid-level drop)
Overall advancement rate: about 25%~30%
Lock-up rate: about 83% (sentiment recovery)
Performance of continuous board sectors yesterday:
3 stocks with 4 boards: +10% (huge profits)
Most 2 boards/first boards advanced: +5%~+10%
Some lagged behind: -2%~-7% (losses)

Profitability Structure

High position (4 boards): Extremely strong
Meinuohua (pharmaceuticals/weight loss), Xinneng Taishan (electricity), Rongjie Co., Ltd. (lithium mining) all hit the daily limit, significant profits from board buying/holding
Mid position (3 boards): Extremely poor
No individual stocks advanced, Hunan Development, etc., directly -7.22% large drop
Low position (2 boards/first boards): Differentiation
Within the main lines of electricity, pharmaceuticals, and lithium mining: high advancement rates, good profitability
Non-main lines: frequent limit breaks/many low openings the next day, clear loss effect

Main Lines and Loss Areas

Profitable main lines:
Pharmaceuticals (weight loss/innovative drugs): Meinuohua, Wanbangde, etc.
Electricity/green energy: Xinneng Taishan, Guangxi Energy, etc.
Lithium mining: Rongjie Co., Ltd., Shida Shenghua, etc.
Loss area:
Mid-level stocks (2 to 3): 0 advanced, large drops concentrated
Non-main line themes, purely sentiment-driven small stocks: limit breaks/many low openings

Short-term Conclusion

Suitable for: making high-position leaders, low-position first boards/2 boards within the main line
Avoid: mid-level 2 to 3, non-main line miscellaneous stocks

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.